Table 1.
Characteristics of donor and recipients.
| Donor | Good Outcome | Suboptimal Outcome | P ‐value |
|---|---|---|---|
| Age y | 53.6 (6.2) | 57.2 (6.2) | 0.195 |
| Male [n (%)] | 7 (63.6%) | 3 (27.3%) | 0.198 |
| BMI [kg/m−2] | 25.9 (4.9) | 26.8 (4.8) | 0.689 |
| History of hypertension [n (%)] | 5 (45.5%) | 4 (36.4%) | 1.000 |
| Terminal serum creatinine | 60.2 (16.6) | 68.6 (24.1) | 0.349 |
| Recipient | Good Outcome | Suboptimal Outcome | P ‐value |
| Age y | 51.6 (9.1) | 57.6(10.8) | 0.174 |
| Male [n (%)] | 7 (63.6%) | 8 (72.7%) | 1.000 |
| BMI [kg/m−2] | 24.0 (3.0) | 25.5 (3.1) | 0.373 |
| ≥3 HLA mismatches [n (%)] | 9 (81.8%) | 6 (54.5%) | 0.361 |
| Ischaemia times | |||
| Total CIT (minutes) | 969.9 (386.6) | 689.18 (323.7) | 0.086 |
| WIT 2 (minutes) | 32.4 | 37.8 (10.3) | 0.264 |
| Renal Outcome | Good Outcome | Suboptimal Outcome | P‐value |
| DGF | 0 (0%) | 5 (45.5%) | 0.035 |
| 3‐month serum creatinine | 95 (88–116) | 189 (176–189) | 0.000 |
| 3‐month eGFR | 68.6 (17.0) | 28 (12.0) | 0.000 |
| 12‐month serum creatinine | 103 (95–117) | 196 (182–230) | 0.000 |
| 12‐month eGFR | 67.4 (15.5) | 27.6 (9.7) | 0.000 |
Data are given as mean (SD), median (IQR) or n (%). n, number in group; BMI, body mass index; HLA, human leukocytes antigens; CIT, cold ischaemia time; WIT2, warm ischaemia time 2; DGF, delayed graft function.